NDC 66887-004 – Testopel

Testosterone 75 mg/1 · Pellet · Subcutaneous

Human Prescription Drug DEA schedule CIII

Product NDC66887-004

Product details

Brand name
Testopel
Generic name
Testosterone
Labeler
Endo USA, Inc.
Dosage form
Pellet
Route
Subcutaneous
Marketing category
ANDA · ANDA080911
Marketed since
October 31, 2014
Listing expires
December 31, 2026
Pharmacologic class
Androgen

Active ingredients

Uses, dosage, side effects and warnings for Testopel →

Package NDC codes (2)

Package NDCDescriptionSince
66887-004-1010 AMPULE in 1 BOX (66887-004-10) / 1 PELLET in 1 AMPULE (66887-004-01)Oct 31, 2014
66887-004-20100 AMPULE in 1 BOX (66887-004-20) / 1 PELLET in 1 AMPULE (66887-004-01)Oct 31, 2014